TNF and Alzheimer disease: Regarding the differences between the different stages of AD, it is important to note that AD patient exhibited a higher IL-6 LPS-induced release (P < 0.05; Figure 2A) and a lower IL-10/TNF-α ratio (P < 0.05; Figure 4D) than mAD patients.